APIMEDS PHARMACEUTICALS US, INC. (APUS) Return on equity
APIMEDS PHARMACEUTICALS US, INC. (APUS) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to APUSSource: SEC XBRL filings · For reference only · Not investment advice
More APUS financial trends
APUS RevenueAPUS Net incomeAPUS Net marginAPUS Gross profitAPUS Gross marginAPUS Operating incomeAPUS Operating marginAPUS Operating cash flowAPUS Free cash flowAPUS Capital expendituresAPUS Stock buybacksAPUS Dividends paidAPUS Total assetsAPUS Total liabilitiesAPUS Shareholders’ equityAPUS overview →